硫酸酯酶
微生物群
异型生物质的
肠道菌群
生物
生物化学
肝肠循环
酶
化学
计算生物学
新陈代谢
生物信息学
作者
Samantha M. Ervin,Joshua B. Simpson,Morgan E. Gibbs,Benjamin C. Creekmore,Lauren Lim,William G. Walton,Raad Z. Gharaibeh,Matthew R. Redinbo
出处
期刊:Biochemistry
[American Chemical Society]
日期:2020-09-29
卷期号:59 (40): 3939-3950
被引量:66
标识
DOI:10.1021/acs.biochem.0c00711
摘要
Phase II drug metabolism inactivates xenobiotics and endobiotics through the addition of either a glucuronic acid or sulfate moiety prior to excretion, often via the gastrointestinal tract. While the human gut microbial β-glucuronidase enzymes that reactivate glucuronide conjugates in the intestines are becoming well characterized and even controlled by targeted inhibitors, the sulfatases encoded by the human gut microbiome have not been comprehensively examined. Gut microbial sulfatases are poised to reactivate xenobiotics and endobiotics, which are then capable of undergoing enterohepatic recirculation or exerting local effects on the gut epithelium. Here, using protein structure-guided methods, we identify 728 distinct microbiome-encoded sulfatase proteins from the 4.8 million unique proteins present in the Human Microbiome Project Stool Sample database and 1766 gut microbial sulfatases from the 9.9 million sequences in the Integrated Gene Catalogue. We purify a representative set of these sulfatases, elucidate crystal structures, and pinpoint unique structural motifs essential to endobiotic sulfate processing. Gut microbial sulfatases differentially process sulfated forms of the neurotransmitters serotonin and dopamine, and the hormones melatonin, estrone, dehydroepiandrosterone, and thyroxine in a manner dependent both on variabilities in active site architecture and on markedly distinct oligomeric states. Taken together, these data provide initial insights into the structural and functional diversity of gut microbial sulfatases, providing a path toward defining the roles these enzymes play in health and disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI